Titan Medical Inc. (TMDI): Price and Financial Metrics


Titan Medical Inc. (TMDI): $1.64

-0.06 (-3.53%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

TMDI Stock Price Chart Interactive Chart >

Price chart for TMDI

TMDI Price/Volume Stats

Current price $1.64 52-week high $3.47
Prev. close $1.70 52-week low $0.57
Day low $1.63 Volume 644,100
Day high $1.72 Avg. volume 2,741,135
50-day MA $1.71 Dividend yield N/A
200-day MA $1.55 Market Cap 179.63M

Titan Medical Inc. (TMDI) Company Bio


Titan Medical Inc. is developing a 3-armed robotic surgical system to permit surgeons to remotely manipulate surgical instruments.


TMDI Latest News Stream


Event/Time News Detail
Loading, please wait...

TMDI Latest Social Stream


Loading social stream, please wait...

View Full TMDI Social Stream

Latest TMDI News From Around the Web

Below are the latest news stories about Titan Medical Inc that investors may wish to consider to help them evaluate TMDI as an investment opportunity.

Titan Medical Reports Voting Results From Annual and Special Meeting of Shareholders

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, today announced the voting results from the company’s Annual and Special Meeting of its Shareholders held on Wednesday, June 9, 2021.

Yahoo | June 10, 2021

Thinking about buying stock in Vertex Energy, AMC Entertainment, Iterum Therapeutics, Yext Inc, or Titan Medical?

NEW YORK , May 28, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VTNR, AMC, ITRM, YEXT, and TMDI.

Benzinga | May 28, 2021

Titan Medical Stock Jumps After Medtronic's $10M Second Milestone Payment

Titan Medical Inc (NASDAQ: TMDI) has received million under the second technical milestone under the development and license agreement with Medtronic plc (NYSE: MDT). The development and license agreement provides for developing robotic-assisted surgical technologies for Titan and Medtronic in their respective businesses. Titan retains worldwide rights to commercialize the developed technologies for use with its own Enos robotic single access surgical system. In October 2020, Titan achieved the first technical milestone and completed a non-technical financial milestone under the development agreement, with the satisfactory raising of $18 million capital. Titan would receive an additional payment of approximately $11 million on completing the third technical milestone, representing the f...

Yahoo | May 28, 2021

Titan Medical Receives License Fee of $10 Million Upon Achievement of Milestone Under Medtronic Development Agreement

Completion of Second Technical Milestone Marks Third Achievement Under Development and License AgreementTORONTO, May 28, 2021 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced today that it has completed the second technical milestone under the development and license agreement with Medtronic plc (NYSE: MDT), and received a U.S. $10 million payment for licensing the developed technologies to Medtronic. The development and license agreement provides for the development of robotic-assisted surgical technologies for use by both Titan and Medtronic in their respective businesses. Titan retains world-wide rights to commercialize the developed tec...

Yahoo | May 28, 2021

Titan Medical Reports First Quarter 2021 Financial Results and Provides Board Update

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announces financial results for the three months ended March 31, 2021. During the first quarter of 2021 the company raised proceeds of $34.5 million from two equity financings and $10 million from the exercise of warrants issued to investors in previous offerings. Titan also announces changes to its board of directors appointing Paul Cataford as Chairman of the Board and Heather Knight as an independent member of the board. In addition, Cathy Steiner has been nominated for election to the Board at the annual and special meeting of shareholders on June 9, 2021.

Yahoo | May 17, 2021

Read More 'TMDI' Stories Here

TMDI Price Returns

1-mo -7.87%
3-mo -12.30%
6-mo 9.33%
1-year 47.75%
3-year -71.09%
5-year -91.80%
YTD -4.09%
2020 245.45%
2019 -59.43%
2018 -86.44%
2017 25.00%
2016 -68.00%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8479 seconds.